Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders
클론 비만 세포 장애 환자에서 효과적인 항 SARS-CoV-2 면역 반응
Article
Published on
Journal: The journal of allergy and clinical immunology. In [Category] COVID19(2023년), MERS, SARS, 진단, 치료제,
Journal: The journal of allergy and clinical immunology. In [Category] COVID19(2023년), MERS, SARS, 진단, 치료제,
[키워드] absence
Activation
acute respiratory syndrome
acute respiratory syndrome coronavirus
Adaptive immune response
anti-SARS-CoV-2
antiviral immune response
antiviral immunity
B cells
Cell
cell activation
characterized
circulating
clinical follow-up
Clonal mast cell activation syndrome
collected
coronavirus
coronavirus disease
Coronavirus disease 2019
correlated
COVID-19
Critical
disorder
ELISA
evaluated
French
hospital
Humoral response
humoral responses
IFN-γ
IgA
IgG
IgGs
immune response
Innate immunity
marker
mast cell
Mast cell activation disorders
Mast cells
Mastocytosis
mechanical ventilation
MOST
Neutralizing
Neutralizing antibodies
noninvasive
outcome
oxygen
Patient
patients
PCR
rare disease
required
respiratory
response
risk
SARS-CoV-2
Serologically
severe coronavirus disease
steroid
steroid therapy
Stimulation
syndrome
T cell
T cells
T-cell
therapy
tryptase
Two patient
two patients
was measured
[DOI] 10.1016/j.jaip.2021.12.038 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jaip.2021.12.038 PMC 바로가기 [Article Type] Article